THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! Registry

por Gabrielle, Pierre-Henry, Nguyen, Vuong, Creuzot-Garcher, Catherine, Arnold, Jennifer J., Mehta, Hemal, Duran, Mónica Asencio, Bougamha, Walid, Carreño, Ester, Viola, Francesco, Squirrell, David, Barthelmes, Daniel, Gillies, Mark
Publicado 2022